Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of Acute Stroke

Treatment of Acute Stroke Editorials represent the opinions EDITORIALS of the authors and THE JOURNAL and not those of the American Medical Association. Still Struggling severity of the damage. Is an infarct present? If so, where, Louis R. Caplan, MD and how extensive? Considering the causative vascular le- sion, how much brain is still at risk for further infarction? N 1998, I WROTE AN EDITORIAL ENTITLED “STROKE TREAT- 1 The third step involves determining potential treatment op- ment: Promising but Still Struggling” in an issue of JAMA 2 tions by comparing the benefits with the risks of each thera- that featured 5 articles on stroke. In that issue, 2 ar- peutic option for the individual patient. Iticles concerned carotid artery surgery, one article re- 12,13 Published guidelines exist for the use of thrombolytic ported the results of a trial of acute stroke patients receiv- therapy in patients with ischemic stroke and are the subject ing treatment with a heparinoid, another focused on of 3 articles in this issue of JAMA. Unfortunately, these guide- anticoagulation in atrial fibrillation, and the fifth reviewed lines are now nearly a decade old and merely restate the in- thrombolytic and neuroprotective treatments—each in their clusions and exclusions of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Treatment of Acute Stroke

JAMA , Volume 292 (15) – Oct 20, 2004

Loading next page...
 
/lp/american-medical-association/treatment-of-acute-stroke-wGGaUbUQPK
Publisher
American Medical Association
Copyright
Copyright 2004 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.292.15.1883
pmid
15494587
Publisher site
See Article on Publisher Site

Abstract

Editorials represent the opinions EDITORIALS of the authors and THE JOURNAL and not those of the American Medical Association. Still Struggling severity of the damage. Is an infarct present? If so, where, Louis R. Caplan, MD and how extensive? Considering the causative vascular le- sion, how much brain is still at risk for further infarction? N 1998, I WROTE AN EDITORIAL ENTITLED “STROKE TREAT- 1 The third step involves determining potential treatment op- ment: Promising but Still Struggling” in an issue of JAMA 2 tions by comparing the benefits with the risks of each thera- that featured 5 articles on stroke. In that issue, 2 ar- peutic option for the individual patient. Iticles concerned carotid artery surgery, one article re- 12,13 Published guidelines exist for the use of thrombolytic ported the results of a trial of acute stroke patients receiv- therapy in patients with ischemic stroke and are the subject ing treatment with a heparinoid, another focused on of 3 articles in this issue of JAMA. Unfortunately, these guide- anticoagulation in atrial fibrillation, and the fifth reviewed lines are now nearly a decade old and merely restate the in- thrombolytic and neuroprotective treatments—each in their clusions and exclusions of

Journal

JAMAAmerican Medical Association

Published: Oct 20, 2004

References